![Drug manufacturing laboratory equipment](https://www.nortonrosefulbright.com/-/media/images/nrf/thought-leadership/canada/publications/life-sciences-healthcare-lab-equipment.jpg?w=265&revision=355955d3-b814-40be-80c7-63b3ad62cb43&revision=5248910870347387904&hash=1F3BEDB56F2489EB29C4E2FCBDED3656)
Publication
Health Canada identifies lithium-ion batteries, infant bath seats, and water beads as hazards of concern
Health Canada has recently identified three new classes of products that pose a hazard of concern.
United Kingdom | Publication | October 2023
The Bank of England has begun the design process in a “journey of 1000 miles” in developing a new lending tool for non-bank financial institutions including pension schemes. This is part of a plan announced in a recent speech to tackle systemic risks, such as those seen in September 2022 in schemes using LDI funds. Although resilience has improved over recent months in schemes using LDI, the Bank’s view is that “safeguarding financial stability requires an effective public backstop”. It intends to work with schemes and the Regulator in development of the new lending tool, although the project is seen as long-term.
Publication
Health Canada has recently identified three new classes of products that pose a hazard of concern.
Publication
An employer’s ability to ask for a sick note when an employee is absent from work due to illness is becoming increasingly curtailed across Canada.
Publication
Since 2022, the Government of Canada has introduced three waves of amendments to the Competition Act (Act), making substantive changes to Canada’s competition laws, with the most recent amendments receiving royal assent on June 20, 2024.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023